P. Pisano

1.1k total citations
37 papers, 875 citations indexed

About

P. Pisano is a scholar working on Molecular Biology, Pathology and Forensic Medicine and Developmental Neuroscience. According to data from OpenAlex, P. Pisano has authored 37 papers receiving a total of 875 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 7 papers in Pathology and Forensic Medicine and 6 papers in Developmental Neuroscience. Recurrent topics in P. Pisano's work include Angiogenesis and VEGF in Cancer (7 papers), Anesthesia and Neurotoxicity Research (6 papers) and Intensive Care Unit Cognitive Disorders (4 papers). P. Pisano is often cited by papers focused on Angiogenesis and VEGF in Cancer (7 papers), Anesthesia and Neurotoxicity Research (6 papers) and Intensive Care Unit Cognitive Disorders (4 papers). P. Pisano collaborates with scholars based in France, United Kingdom and United States. P. Pisano's co-authors include Benjamin Guillet, Lionel Velly, L. Pellegrini, Nicolas Bruder, Françoise Dignat‐George, Florence Sabatier, Youssef Bennis, Alexandrine Foucault‐Bertaud, Marcel Blot-Chabaud and Marie‐Dominique Piercecchi and has published in prestigious journals such as Blood, Circulation Research and Biochemical and Biophysical Research Communications.

In The Last Decade

P. Pisano

36 papers receiving 854 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
P. Pisano France 16 317 151 100 96 88 37 875
Oliver Schmidt Germany 12 283 0.9× 52 0.3× 47 0.5× 78 0.8× 89 1.0× 12 1.1k
Shigeharu Takagi Japan 20 177 0.6× 75 0.5× 85 0.8× 86 0.9× 222 2.5× 102 1.3k
Çağnur Ulukuş Türkiye 16 204 0.6× 36 0.2× 105 1.1× 123 1.3× 36 0.4× 36 1.2k
Francesca Paoloni Italy 16 115 0.4× 84 0.6× 129 1.3× 120 1.3× 16 0.2× 40 1.1k
Christof Huth Germany 24 488 1.5× 157 1.0× 27 0.3× 69 0.7× 134 1.5× 54 3.3k
Ernst Hund Germany 23 847 2.7× 38 0.3× 151 1.5× 60 0.6× 87 1.0× 57 2.1k
Alessandra Repetto Italy 22 376 1.2× 96 0.6× 73 0.7× 188 2.0× 231 2.6× 68 1.8k
José Pineda United States 23 624 2.0× 105 0.7× 40 0.4× 107 1.1× 60 0.7× 54 1.5k
Uwe Schirmer Germany 29 446 1.4× 238 1.6× 31 0.3× 102 1.1× 68 0.8× 94 2.1k
Oliver J. Ziff United Kingdom 21 312 1.0× 44 0.3× 134 1.3× 97 1.0× 26 0.3× 40 1.3k

Countries citing papers authored by P. Pisano

Since Specialization
Citations

This map shows the geographic impact of P. Pisano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P. Pisano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P. Pisano more than expected).

Fields of papers citing papers by P. Pisano

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P. Pisano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P. Pisano. The network helps show where P. Pisano may publish in the future.

Co-authorship network of co-authors of P. Pisano

This figure shows the co-authorship network connecting the top 25 collaborators of P. Pisano. A scholar is included among the top collaborators of P. Pisano based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P. Pisano. P. Pisano is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Stalin, Jimmy, Karim Harhouri, Philippe Garrigue, et al.. (2016). Soluble CD146 boosts therapeutic effect of endothelial progenitors through proteolytic processing of short CD146 isoform. Cardiovascular Research. 111(3). 240–251. 28 indexed citations
2.
Bennis, Youssef, et al.. (2015). Stability of a highly concentrated solution of epirubicin for conventional transcatheter arterial chemoembolization. International Journal of Pharmaceutics. 495(2). 956–962. 3 indexed citations
3.
Pourroy, Bertrand, et al.. (2015). Pertinence des prescriptions « hors AMM/RTU » des molécules onéreuses dans un hôpital universitaire. Therapies. 70(5). 385–402. 2 indexed citations
4.
Bennis, Youssef, et al.. (2014). Cisplatin dose adjustment in patients with renal impairment, which recommendations should we follow?. International Journal of Clinical Pharmacy. 36(2). 420–429. 26 indexed citations
5.
Curti, Christophe, et al.. (2013). Actualités dans le traitement étiologique de la sclérose latérale amyotrophique. Therapies. 68(2). 93–106. 1 indexed citations
6.
Pellegrini, L., Youssef Bennis, Benjamin Guillet, et al.. (2012). La thérapie cellulaire de l’accident vasculaire cérébral ischémique : du mythe à la réalité. Revue Neurologique. 169(4). 291–306. 6 indexed citations
7.
Pisano, P., et al.. (2011). La thérapie génique dans la maladie de Parkinson : un traitement d’avenir ?. Therapies. 66(5). 413–419.
8.
Harhouri, Karim, Benjamin Guillet, Alexandrine Foucault‐Bertaud, et al.. (2010). Soluble CD146 displays angiogenic properties and promotes neovascularization in experimental hind-limb ischemia. Blood. 115(18). 3843–3851. 72 indexed citations
9.
Guillet, Benjamin, Nicolas Simon, Raj Purgus, et al.. (2010). Population Pharmacokinetics Analysis of Mycophenolic Acid in Adult Kidney Transplant Patients With Chronic Graft Dysfunction. Therapeutic Drug Monitoring. 32(4). 427–432. 14 indexed citations
10.
Bennis, Youssef, Benjamin Guillet, Christophe Curti, & P. Pisano. (2010). Intérêts thérapeutiques des médicaments antiangiogéniques disponibles en cancérologie. Therapies. 65(2). 95–105. 1 indexed citations
11.
Guillet, Benjamin, Youssef Bennis, Marie‐Dominique Piercecchi, et al.. (2010). Transplanted Late Outgrowth Endothelial Progenitor Cells as Cell Therapy Product for Stroke. Stem Cell Reviews and Reports. 7(1). 208–220. 118 indexed citations
12.
13.
Lancelot, Sophie, et al.. (2008). Exposure of medical personnel to radiation during radionuclide therapy practices. Nuclear Medicine Communications. 29(4). 405–410. 14 indexed citations
14.
Monjanel‐Mouterde, Suzanne, M. Gasquet, F. Delmas, et al.. (2005). Lack of toxicity of hydroethanolic extract from Mitragyna inermis (Willd.) O. Kuntze by gavage in the rat. Journal of Ethnopharmacology. 103(3). 319–326. 9 indexed citations
15.
Blin, Olivier, Nicolas Simon, Élisabeth Jouve, et al.. (2001). Pharmacokinetic and Pharmacodynamic Analysis of Sedative and Amnesic Effects of Lorazepam in Healthy Volunteers. Clinical Neuropharmacology. 24(2). 71–81. 37 indexed citations
16.
Gantenbein, Manon, et al.. (1997). Ketamine effects on bupivacaine local anaesthetic activity and pharmacokinetics of bupivacaine in mice. Life Sciences. 61(20). 2027–2033. 26 indexed citations
17.
Pisano, P., Alain Durand, E Autret, et al.. (1996). Plasma concentrations and pharmacokinetics of idebenone and its metabolites following single and repeated doses in young patients with mitochondrial encephalomyopathy. European Journal of Clinical Pharmacology. 51(2). 167–169. 9 indexed citations
18.
Sérée, Eric, et al.. (1995). Evidence for the Existence of Two Human CYP2E1 cDNAs Using Different Polyadenylation Signals. Biochemical and Biophysical Research Communications. 209(2). 717–722. 1 indexed citations
19.
Lacarelle, Bruno, et al.. (1994). Abbott PKS system: A new version for applied pharmacokinetics including Bayesian estimation. International Journal of Bio-Medical Computing. 36(1-2). 127–130. 13 indexed citations
20.
Pisano, P., et al.. (1991). 1H nuclear magnetic resonance and clinical studies of interaction of calcium antagonists and hypoglycemic sulfonylureas. Fundamental and Clinical Pharmacology. 5(6). 527–538. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Oliver Schmidt Breakdown of academic impact, for papers by Shigeharu Takagi Breakdown of academic impact, for papers by Çağnur Ulukuş Breakdown of academic impact, for papers by Francesca Paoloni Breakdown of academic impact, for papers by Christof Huth Breakdown of academic impact, for papers by Ernst Hund Breakdown of academic impact, for papers by Alessandra Repetto Breakdown of academic impact, for papers by José Pineda Breakdown of academic impact, for papers by Uwe Schirmer Breakdown of academic impact, for papers by Oliver J. Ziff
Rankless by CCL
2026